Coagulation substrate role

The term "Coagulation substrate role" refers to a functional category of proteins within the blood coagulation cascade rather than a single specific molecular target. These proteins serve as the physical building blocks or essential cofactors that are acted upon by proteolytic enzymes (such as thrombin or Factor Xa) to produce a stable fibrin clot (StatPearls, 2023). The primary substrate in this pathway is Fibrinogen (Factor I), which is converted into fibrin monomers that polymerize to form the structural framework of a blood clot (PubMed, PMID: 15507107). Other key substrates include Factor V, Factor VIII, and Factor XIII, which are modified to enhance the rate of thrombin generation or to cross-link fibrin strands for increased stability (UniProt, P00451, P00488). In therapeutic contexts, these substrates are frequently used as replacement therapies for patients with hereditary or acquired deficiencies, such as Hemophilia A (Factor VIII deficiency) or afibrinogenemia (NIH, 2022). Additionally, certain drugs like snake venom-derived enzymes (e.g., Ancrod) directly target these substrates to deplete them and prevent thrombosis. Because "Coagulation substrate role" describes a biological function shared by multiple distinct proteins rather than a specific gene product or receptor, it is considered an imprecise or incorrect designation for a single therapeutic target in drug discovery databases.

Other names

Coagulation substrateClotting substrateHemostatic substrateProcoagulant substrate

Replacement of deficient substrate proteins to restore hemostatic function or enzymatic cleavage of substrates to induce or prevent clot formation.